The price of Aurora Cannabis Inc. (NASDAQ: ACB) closed at $0.59 in the last session, down -3.56% from day before closing price of $0.62. In other words, the price has decreased by -$0.0219 from its previous closing price. On the day, 2497699 shares were traded. ACB stock price reached its highest trading level at $0.6137 during the session, while it also had its lowest trading level at $0.5870.

**Unlock the Hottest Top 10 Penny Stocks Today! Discover Now**

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

**Gain Access to Top 10 Penny Stocks Now!**.

Sponsored

### Ratios:

We take a closer look at ACB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.40 whereas as Long-Term Debt/Eq ratio is at 0.35.

### Upgrades & Downgrades

### Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 200.06M and an Enterprise Value of 176.00M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.19 while its Price-to-Book (P/B) ratio in mrq is 0.35. Its current Enterprise Value per Revenue stands at 0.83 whereas that against EBITDA is -0.11.

### Stock Price History:

The Beta on a monthly basis for ACB is 2.97, which has changed by -78.24% over the last 52 weeks, in comparison to a change of 1.41% over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $2.80, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is 0.6429, while the 200-Day Moving Average is calculated to be 1.0460.

### Shares Statistics:

According to the various share statistics, ACB traded on average about 3.48M shares per day over the past 3-months and 3.36M shares per day over the past 10 days. A total of 326.45M shares are outstanding, with a floating share count of 299.83M. Insiders hold about 0.06% of the company’s shares, while institutions hold 17.37% stake in the company. Shares short for ACB as of Apr 27, 2023 were 31.39M with a Short Ratio of 31.39M, compared to 31.14M on Mar 30, 2023.

### Earnings Estimates

The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.07, while EPS last year was -$3.63. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.04 and low estimates of -$0.07.

Analysts are recommending an EPS of between -$0.14 and -$0.36 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.17, with 8 analysts recommending between -$0.07 and -$0.29.

### Revenue Estimates

According to 8 analysts, the current quarter’s revenue is expected to be $48.21M. It ranges from a high estimate of $50M to a low estimate of $43.39M. As of the current estimate, Aurora Cannabis Inc.’s year-ago sales were $37.83M, an estimated increase of 27.50% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $47.5M, an increase of 26.60% less than the figure of $27.50% in the same quarter last year. There is a high estimate of $48.13M for the next quarter, whereas the lowest estimate is $46.87M.

A total of 10 analysts have provided revenue estimates for ACB’s current fiscal year. The highest revenue estimate was $200.62M, while the lowest revenue estimate was $127.07M, resulting in an average revenue estimate of $146.57M. In the same quarter a year ago, actual revenue was $165.43M, down -11.40% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $203.84M in the next fiscal year. The high estimate is $242.04M and the low estimate is $187.35M. The average revenue growth estimate for next year is up 39.10% from the average revenue estimate for this year.